The November election is over, but the real campaign has just begun. For urologists, that means urgent action on efforts to reverse the payment cuts mandated by the sustainable growth rate formula and the fiscal cliff, to name two immediate priorities.
Empiric use of antibiotics for a newly elevated PSA measurement in asymptomatic men appears to have no clinical benefit, according to results of a recent multicenter study.
Researchers at Northwestern University in Chicago are exploring the complex web woven by cytokines in uropathogenic Escherichia coli bladder infections and in so doing, are opening avenues for potential therapies for these infections.
Obesity may have a significant effect on prostate growth, a new analysis of the original data collected in a prospective, randomized, placebo-controlled clinical trial indicates.
A recent report from the Center for Public Integrity found that during a 10-year period, physicians increasingly billed Medicare for higher paying codes than in the past.
Patients younger than 50 years of age at the time of radical prostatectomy appear to have more favorable disease characteristics, data from a European consecutive cohort of non-screened men with clinically localized disease show.
A more thoughtful approach to antimicrobial prophylaxis is to obtain rectal swab cultures ahead of time and determine which bacteria are susceptible to antibiotics.
In this article, James M. Dupree, MD, MPH; Maddie Jones; and Christopher M. Gonzalez, MD, MBA explain what constitutes an accountable care organization and how a urologist might (or might not) interact with one.
Bicalutamide monotherapy in men with locally advanced or metastatic prostate cancer is as initially effective as LHRH analogs but can be far more beneficial in preserving bone mineral density, muscle tone, sexual function, and quality of life, say British researchers.
In this article, Joel M. Blau, CFP, and Ronald J. Paprocki, JD, CFP, CHBC discuss dynasty trusts and employee 401(k) programs.
In this article, Robert A. Dowling, MD, describes some of the important differences and practical aspects of Stage 2 meaningful use as they related to "eligible professionals."
Products and services in the pipeline from Nymox Pharmaceuticals Corp.; OncoGenex Pharmaceuticals, Inc.; Ampio Pharmaceuticals, Inc.; Aragon Pharmaceuticals; Sophiris Bio Inc.; Genomic Health, Inc.; OxThera AB; Aeterna Zentaris Inc.; and Tengion, Inc.
Photoselective laser vaporization of the prostate performed prior to external beam radiation therapy appears to be a viable approach for managing symptomatic BPH in men with concomitant prostate cancer, according to the findings of a retrospective study.
A screening protocol to guide antibiotic prophylaxis prior to prostate biopsy that eliminates the broth enrichment provides the best sensitivity with the fewest false- positive rates.
If a nephrostomy tube removal is performed in conjunction with another service, such as an evaluation and management service, you should either report the other service(s) documented and consider the nephrostomy tube removal incidental or add a –22 to the other service if documentation supports a significant increase in effort.
The latest products and services from Ethicon Endo-Surgery, InSightec Ltd., Watson Pharmaceuticals, Coloplast, Envaste Ltd., Cardinal Health, Medline Industries, Inc., and DocBookMD.
Here are some problems delayed billing present and how you can avoid them.
This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase II, III, and IV urinary incontinence trials that are currently recruiting participants.
Men with moderate to severe lower urinary tract symptoms associated with BPH obtained significant symptom relief with the phosphodiesterase type-5 inhibitor tadalafil (Cialis) and the alpha-blocker tamsulosin (Flomax), both of which also improved urinary flow, results of a randomized trial showed.
Researchers teasing out the relationship between urinary tract infection and its symptoms are zeroing in on the major component of Escherichia coli's cell wall, lipopolysaccharide (LPS), as the culprit.
In this interview, Barry A. Kogan, MD, discusses the status of advanced practice practitioners in urology, their education, training, and scope of practice.
On-demand use of a phosphodiesterase type-5 inhibitor did not affect prostatic or urinary outcomes of therapy for BPH, a post hoc analysis of a large randomized trial showed.
Primary therapy for prostate cancer does not reduce the frequency of end-of-life urologic procedures, according to the findings of a population-based study.
Urologists discuss whether burnout affects them and, if so, what they do to cope.
Here are some resources regarding laws and regulations governing nurse practitioners and physician assistants in your state.
Urologist Catherine R. deVries, MD, has been named a recipient of the American College of Surgeons 2012 Surgical Humanitarian Award.
Uroplasty, Inc. recently announced an expansion of coverage of percutaneous nerve stimulation (PTNS) using its Urgent PC neuromodulation system for the treatment of symptoms of overactive bladder syndrome.
Men with prostate cancer who consumed green tea prior to undergoing prostatectomy had reductions in markers of inflammation, say researchers from UCLA’s David Geffen School of Medicine.
The method of toilet training chosen by parents has no bearing on urinary accidents in children, new research shows.
Patients undergoing treatment for prostate cancer using proton beam therapy reported a higher quality of life in early follow-up but similar QoL scores at 2 years compared to 3-D conformal and intensity-modulated radiation therapy, according to a new study.